Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05746429 · ClinicalTrials.gov registry record · NA
Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer
A NA study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT05746429 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 68 participants.
The verdict
NCT05746429, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
This is a prospective study that will conduct a series of focus groups with non-Hispanic Black and Hispanic childhood cancer survivors to obtain their input on culturally adapting a mobile CBT program for chronic pain and tDCS procedures. Once this adaptation process is completed, the investigators will conduct a feasibility trial with non-Hispanic Black, Hispanic and non-Hispanic White survivors of childhood cancer with chronic pain. The feasibility study will assign eligible participants to either culturally adapted mobile CBT + active tDCS to the dorsolateral prefrontal cortex or culturally adapted mobile CBT + sham tDCS. We anticipate approximately 60 participants for the focus groups and approximately 30 participants for the feasibility study for a total of about 90 participants.
Interventions
- OTHER Questionnaire Administration
- OTHER Interview
- DRUG Placebo Administration
- DEVICE Transcranial Direct Current Stimulation
- BEHAVIORAL Cognitive Behavior Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2023-04-06 |
| Est. Completion | 2024-10-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05746429
The ClinicalTrials.gov registry entry for NCT05746429 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT05746429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05746429 about?
NCT05746429 is a clinical study titled "Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer". This is a prospective study that will conduct a series of focus groups with non-Hispanic Black and Hispanic childhood cancer survivors to obtain their input on culturally adapting a mobile CBT program for chronic pain and tDCS procedures. Once this adaptation process is completed, the investigators ...
What is the current status of trial NCT05746429?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2023-04-06. Estimated completion is 2024-10-29.
What interventions are being tested in trial NCT05746429?
The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER), Placebo Administration (DRUG), Transcranial Direct Current Stimulation (DEVICE), Cognitive Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05746429?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.